Log in or Sign up for Free to view tailored content for your specialty!
Oncology News
Trial of mirvetuximab soravtansine for ovarian cancer meets response rate endpoint
A trial investigating mirvetuximab soravtansine monotherapy in certain patients with platinum-sensitive ovarian cancer met its primary endpoint of improved objective response rate, according to the agent’s manufacturer.
High insulin levels may drive worse breast cancer outcomes for Black women
BOSTON — Tumor samples from Black women diagnosed with triple-negative breast cancer expressed higher levels of insulin signaling than samples from white women, suggesting hyperinsulinemia may play a role in disease outcomes, data show.
Log in or Sign up for Free to view tailored content for your specialty!
Weight gain of 10% or more common among breast cancer survivors
BOSTON — Breast cancer survivors are more likely to have weight gain of 10% or more during follow-up compared with healthy controls, with the strongest predictors younger age at diagnosis and lower weight at baseline, data show.
Trastuzumab deruxtecan improves PFS in pretreated breast cancer
CHICAGO — Trastuzumab deruxtecan extended PFS compared with standard chemotherapy for certain patients with pretreated breast cancer, according to findings presented at ASCO Annual Meeting.
Keytruda extends survival in high-risk triple negative breast cancer
A study assessing the efficacy of pembrolizumab met a key secondary endpoint of extending OS, in combination with chemotherapy, among patients with high-risk early-stage triple-negative breast cancer, according to the agent’s manufacturer.
Type of menopausal hormone therapy may influence cancer risk
CHICAGO — Cancer risk among women varied based on the type of menopausal hormone therapy they used, according to randomized study results scheduled for presentation at ASCO Annual Meeting.
HPV vaccination linked to lower risk for related cancers among men
Men vaccinated for HPV less frequently developed all related cancers, particularly head and neck cancers, according to findings scheduled for presentation at ASCO Annual Meeting.
Most young women can conceive, give birth after breast cancer treatment
CHICAGO — The majority of young breast cancer survivors who attempted pregnancy became pregnant, according to prospective study results scheduled for presentation at ASCO Annual Meeting.
School vaccination program increased HPV coverage for adolescents in France
In France, HPV vaccination at school significantly increased vaccination coverage among adolescents aged 11 to 14 years, according to study results published in JAMA Network Open.
Data show longer intervals between HPV testing likely safe
A 5-year interval between cervical cancer screenings using HPV testing does not increase risk for cervical precancer detection compared with cytology every 3 years and may be a more effective screening method long term, researchers report.
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read